Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-21

Clinical Trial Update: A Randomized, Double-blind Placebo-Controlled Pharmacogenetic Study of Topiramate in European-American Heavy Drinkers [Phase 2]

View source ↗

Summary

Phase 2 randomized, double-blind placebo-controlled pharmacogenetic study of topiramate in European-American heavy drinkers has completed; results posted in 202…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topiramate (Topiramate)

Snippet

Sponsor: University of Pennsylvania | Conditions: Alcoholism, Alcohol Use Disorder (AUD) | Phase 2 | Status: COMPLETED | Results posted: 2021-02-21